Stockreport

Wall Street Analysts Predict an 117.91% Upside in Monte Rosa Therapeutics (GLUE): Here's What You Should Know [Yahoo! Finance]

Monte Rosa Therapeutics, Inc.  (GLUE) 
PDF still be a solid upside left in the stock if short-term price targets of Wall Street analysts are any indication. Going by the price targets, the mean estimate of $14.60 [Read more]